小脑卒中评分与分级量表用于预测缺血性小脑卒中的死亡与结局
这项多中心回顾性研究纳入2008至2021年德国5个学术神经外科和神经内科的531例缺血性小脑卒中患者,通过逻辑回归确定30天死亡和不良结局的独立预测因素,并据此开发并内部验证了缺血性小脑卒中评分(CS-score)和小脑卒中分级量表(CS-GS)。两个量表评分越高,30天死亡率和不良结局率越高(P<0.001),作者认为其简单准确,虽可能不直接影响治疗决策,但有助于与患者和照护者讨论死亡与结局。
要点
- CS-score由年龄≥70岁(2分)、脑干受累(2分)、入院GCS 3-4分(1分)、卒中体积≥25 cm3(1分)组成,总分0-6分。
- CS-GS在CS-score基础上增加合并症变量,GCS 3-4分改为3分,其余参数各1分,总分0-7分。
- CS-score 0-6分对应30天死亡率分别为1%、6%、6%、17%、21%、55%、67%,CS-GS 0-7分对应30天不良结局率分别为1%、17%、33%、40%、50%、80%、77%、100%。
核心结论
- CS-score和CS-GS是简单准确的量表,用于预测小脑卒中患者30天死亡和不良结局。
- 作者认为该评分系统可能不直接影响治疗决策,但可能有助于与患者和照护者讨论死亡和结局。
研究设计与样本
- 多中心回顾性研究,纳入2008至2021年德国5个学术神经外科和神经内科的531例缺血性小脑卒中患者。
- 采用逻辑回归分析确定与30天死亡和不良结局(改良Rankin量表评分4-6分)相关的独立预测因素。
- 通过回归系数计算对每个参数加权,开发缺血性CS-score和CS-GS并进行内部验证。
主要发现
- 30天死亡的独立预测因素为年龄≥70岁(比值比5.2)、入院GCS 3-4分(比值比2.6)、卒中体积≥25 cm3(比值比2.7)和脑干受累(比值比3.9)。
- CS-score 0、1、2、3、4、5、6分对应的30天死亡率分别为1%、6%、6%、17%、21%、55%、67%。
- CS-GS 0、1、2、3、4、5、6、7分对应的30天不良结局率分别为1%、17%、33%、40%、50%、80%、77%、100%。
- 30天死亡率和不良结局均随CS-score和CS-GS升高而增加(P<0.001)。
关键数值与推荐
- CS-score:年龄≥70岁计2分,脑干卒中计2分,入院GCS 3-4分计1分,卒中体积≥25 cm3计1分,总分0-6分。
- CS-GS:除入院GCS 3-4分计3分外,其余参数各计1分,总分0-7分。
临床怎么用
- 作者认为该评分系统可能不直接影响治疗决策,但可能有助于与患者和照护者讨论死亡和结局。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Several individual predictors for outcomes in patients with cerebellar stroke (CS) have been previously identified. There is, however, no established clinical score for CS. Therefore, the aim of this study was to develop simple and accurate grading scales for patients with CS in an effort to better estimate mortality and outcomes. METHODS: This multicentric retrospective study included 531 patients with ischemic CS presenting to 5 different academic neurosurgical and neurological departments throughout Germany between 2008 and 2021. Logistic regression analysis was performed to determine independent predictors related to 30-day mortality and unfavorable outcome (modified Rankin Scale score of 4-6). By weighing each parameter via calculation of regression coefficients, an ischemic CS-score and CS-grading scale (CS-GS) were developed and internally validated. RESULTS: Independent predictors for 30-day mortality were aged ≥70 years (odds ratio, 5.2), Glasgow Coma Scale score 3 to 4 at admission (odds ratio, 2.6), stroke volume ≥25 cm3 (odds ratio, 2.7), and involvement of the brain stem (odds ratio, 3.9). When integrating each parameter into the CS-score, age≥70 years and brain stem stroke were assigned 2 points, Glasgow Coma Scale score 3 to 4, and stroke volume≥25 cm3 1 point resulting in a score ranging from 0 to 6. CS-score of 0, 1, 2, 3, 4, 5, and 6 points resulted in 30-day mortality of 1%, 6%, 6%, 17%, 21%, 55%, and 67%, respectively. Independent predictors for 30-day unfavorable outcomes consisted of all components of the CS-score with an additional variable focused on comorbidities (CS-GS). Except for Glasgow Coma Scale score 3 to 4 at admission, which was assigned 3 points, all other parameters were assigned 1 point resulting in an overall score ranging from 0 to 7. CS-GS of 0, 1, 2, 3, 4, 5, 6, and 7 points resulted in 30-day unfavorable outcome of 1%, 17%, 33%, 40%, 50%, 80%, 77%, and 100%, respectively. Both 30-day mortality and unfavorable outcomes increased with increasing CS-score and CS-GS (P<0.001). CONCLUSIONS: The CS-score and CS-GS are simple and accurate grading scales for the prediction of 30-day mortality and unfavorable outcome in patients with CS. While the score systems proposed here may not directly impact treatment decisions, it may help discuss mortality and outcome with patients and caregivers.
引用
- Won SY, Melkonian R, Behmanesh B, et al. Cerebellar Stroke Score and Grading Scale for the Prediction of Mortality and Outcomes in Ischemic Cerebellar Stroke. Stroke. 2023. PMID: 37551591. doi:10.1161/STROKEAHA.123.043478
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。